# FDA recall D-247-2013

> **Teva Pharmaceuticals USA, Inc.** · Class II · drug recall initiated 2013-02-26.

## Product

Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA  18960.

## Reason for recall

Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-247-2013
- **Recalling firm:** Teva Pharmaceuticals USA, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-02-26
- **Report date:** 2013-04-17
- **Termination date:** 2014-01-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sellersville, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-247-2013

## Citation

> AI Analytics. FDA recall D-247-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-247-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*